Jump to Main Content

2021 Highlights of ASH®

A Virtual Experience

Participate in Highlights of ASH to get a synopsis of the top hematology research presented at the latest ASH annual meeting and learn how it can help improve your patient management and care strategies. This meeting is your chance to discuss rapidly evolving developments and hematology-oncology with leading faculty in the field, discover new treatments for patients, and improve overall practice methods.


March 1 – April 2, 2021
A Virtual Experience

Plan to attend the ONLY official Highlights of ASH for synopses of the top hematology research presented at the 62nd ASH Annual Meeting and Exposition this past December. This meeting is your chance to discuss rapidly evolving developments in hematology with leading faculty in the field, discover new treatments for patients, and improve overall practice methods.

This year’s all-virtual experience will take place between March 1 and April 2 and will feature curated annual meeting content that is relevant to all regions in which ASH has historically presented, including North America, the Mediterranean, Asia-Pacific, and Latin America. Attendees will receive full access to the entire program and content on the virtual platform until April 2, including: 

  • Content categorized by region and released between March 1 and April 2 will enable attendees from around the world to integrate these sessions into their schedules more effectively.
  • New this year! Community Nights, featuring live interactive sessions summarizing each regional and thematic area, as well as Q&A opportunities with session panelists.
  • CME will be available for participating in on-demand OR live sessions; attendees do not need to watch sessions “live” and can participate in a “watch again” format in order to claim credits.  
  • Access to virtual exhibits and virtual Satellite Symposia will enable attendees to network with industry partners and learn about the latest products and services available.

registration

Highlights of ASH Steering Subcommittee

  • Marc Khan, MD, MBA – Chair
  • John Burke, MD
  • Christopher Flowers, MD
  • James Foran, MD
  • Peter Kouides, MD
  • Alice Ma, MD
  • Ifeyinwa Osunkwo, MD, MPH
  • Eric Tse, PhD
  • Neil Zakai, MD

Support

ASH would like to acknowledge the following companies for the educational grants provided in support of the 2021 Highlights of ASH:

Asia-Pacific

  • AstraZeneca
  • Millennium Pharmaceuticals, Inc.
  • Pfizer Inc.

Latin America

  • AstraZeneca
  • Pfizer Inc.

Mediterranean

  • AstraZeneca
  • Pfizer Inc.

North America

  • Amgen, Inc.
  • Astellas Pharma US, Inc.
  • AstraZeneca
  • Bristol Myers Squibb
  • Gilead Sciences, Inc.
  • Incyte Corporation
  • Janssen Biotech, Inc.
  • Jazz Pharmaceuticals, Inc.
  • Kite Pharma, Inc.
  • Merck & Co., Inc.
  • Novartis Pharmaceuticals
  • Pfizer Inc.
  • Pharmacyclics LLC
  • Seagen
  • TG Therapeutics, Inc.

Get email updates